Q: Would you advise against selling CTS for a "medium" sized tax-loss harvest at this time? If not, what would you recommend to proxy?
5i Research Answer:
Because it is undergoing a strategic review, selling becomes a little riskier, in case news breaks. But we do doubt the review will be over before the calendar turns, so would still be 'OK' with a tax loss/re-buy strategy. We would play it safer on a proxy and suggest ENGH.